Caxton Associates (New York)’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,524
Closed -$205K 605
2023
Q1
$205K Buy
+3,524
New +$203K 0.03% 417

Other funds holding NHC

Caxton Associates (New York)'s NHC Position: Q2 2023 in Review

Caxton Associates (New York) sold out of National Healthcare (NHC) in Q2 2023, closing a stake of 3,524 shares — an estimated $205K sold.

Caxton Associates (New York) first reported a position in NHC in Q1 2023 and held it in 1 quarter. The position peaked at $205K in Q1 2023. 132 funds tracked by Wall St. Rank hold NHC as of Q2 2023.

  • Caxton Associates (New York) reported no remaining National Healthcare position as of Q2 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,524 National Healthcare shares in Q2 2023, an estimated $205K.
  • Caxton Associates (New York) first reported a position in National Healthcare in Q1 2023 and held it in 1 quarter.
  • Caxton Associates (New York)'s National Healthcare position peaked at $205K in Q1 2023.
  • 132 funds tracked by Wall St. Rank held National Healthcare as of Q2 2023.

Based on Caxton Associates (New York)'s 13F filing for Q2 2023, filed 15 Aug 2023.